ArticleBiomedical optics express2025
Optical imaging unveils morphological heterogeneity at the hepatic lobule level during metabolic dysfunction-associated fatty liver disease progression [Invited].
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Atractylenolide I stabilizes HMOX1 to induce ferroptosis and enhance lenvatinib efficacy in hepatocellular carcinoma.iScience · 2026Article
- Review
- [Dual-wavelength photoacoustic microscopy for evaluation of microcirculatory dysfunction and spatial heterogeneity in mice with liver fibrosis].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026Article
- Introduction to the feature issue Photoacoustic Imaging and Sensing: Beyond Fundamentals to Translation.Biomedical optics express · 2026Article
- Photoacoustic Microscopy for Multiscale Biological System Visualization and Clinical Translation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatic lobules constitute the fundamental structural and functional units of the liver, which are essential for maintaining microcirculatory homeostasis, barrier integrity, and metabolic clearance. Optical imaging techniques, including photoacoustic microscopy (PAM) and near-infrared-II (NIR-II) fluorescence imaging, have been extensively employed to investigate liver structure and function. However, few studies have specifically addressed the structural and functional heterogeneity at the lobular level. In this study, we developed a dual-modal approach combining high-resolution PAM and dynamical NIR-II fluorescence imaging to assess hepatic lobular vascular structure, permeability, and metabolic function in the models of metabolic dysfunction-associated fatty liver disease (MAFLD). PAM imaging revealed progressive vascular disorganization and increased morphological heterogeneity during fibrosis, while Evans blue (EB) permeability analysis showed elevated regional differences in vascular permeability. NIR-II imaging further demonstrated reduced hepatic lobular functional reserve in livers with hepatic steatosis. This approach underscores hepatic lobular heterogeneity during MAFLD progression. Collectively, this study presents a hepatic lobule-level optical imaging framework that enables integrated assessment of microstructural remodeling, vascular permeability, and metabolic function, providing new insights into intra-lobular heterogeneity during the progression of MAFLD.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.